Irinotecan,Cetuximab,Bevacizumab,regorafenib
Ipsen,eli lilly,roche,Bayer
[]
best of luck to all the speakers at #gi23 over the next few days, including 's dr sebastian stintzing ( ), who is presenting an update on the phase iii fire-4 study, abstract #100, poster #e17. see more #crc #crcsm #meded
Independent and international experts in GastroIntestinal (GI) and Liver (HCC) Oncology nursing in collaboration with COR2ED as providers of independent #MedEd